Literature DB >> 32819613

Cytoreduction and the Optimization Of Immune Checkpoint Inhibition with Radiation Therapy.

Stanley I Gutiontov1, Sean P Pitroda1, Steven J Chmura1, Ainhoa Arina1, Ralph R Weichselbaum2.   

Abstract

Mesh:

Substances:

Year:  2020        PMID: 32819613     DOI: 10.1016/j.ijrobp.2019.12.033

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  7 in total

1.  Dimethylaminomicheliolide Sensitizes Cancer Cells to Radiotherapy for Synergistic Combination with Immune Checkpoint Blockade.

Authors:  Yingying Li; Kaiyuan Ni; Christina Chan; Nining Guo; Taokun Luo; Wenbo Han; August Culbert; Ralph R Weichselbaum; Wenbin Lin
Journal:  Adv Ther (Weinh)       Date:  2021-10-03

2.  Circulating Lymphocyte Counts Early During Radiation Therapy Are Associated With Recurrence in Pediatric Medulloblastoma.

Authors:  Clemens Grassberger; Daniel Shinnick; Beow Y Yeap; Mark Tracy; Susannah G Ellsworth; Clayton B Hess; Elizabeth A Weyman; Sara L Gallotto; Miranda P Lawell; Benjamin Bajaj; David H Ebb; Myrsini Ioakeim-Ioannidou; Jay S Loeffler; Shannon M MacDonald; Nancy J Tarbell; Torunn I Yock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-02-05       Impact factor: 8.013

Review 3.  The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer.

Authors:  Quinn Storozynsky; Mary M Hitt
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

Review 4.  Combining Radiotherapy and Immunotherapy in Metastatic Breast Cancer: Current Status and Future Directions.

Authors:  Steven David; Jennifer Tan; Shankar Siva; Lama Karroum; Peter Savas; Sherene Loi
Journal:  Biomedicines       Date:  2022-03-31

Review 5.  Modeling of radiation effects to immune system: a review.

Authors:  Wonmo Sung; Byungchul Cho
Journal:  J Korean Phys Soc       Date:  2022-08-08       Impact factor: 0.657

Review 6.  Therapy-Induced Modulation of the Tumor Microenvironment: New Opportunities for Cancer Therapies.

Authors:  Sergi Benavente; Almudena Sánchez-García; Silvia Naches; Matilde Esther LLeonart; Juan Lorente
Journal:  Front Oncol       Date:  2020-10-23       Impact factor: 6.244

Review 7.  Durable Metastatic Melanoma Remission Following Pembrolizumab and Radiotherapy: A Case Report of Prophylactic Immunosuppression in a Patient with Myasthenia Gravis and Immune-Mediated Colitis.

Authors:  Luke A Moradi; Curtis A Clark; Craig S Schneider; Alok S Deshane; Michael C Dobelbower
Journal:  Front Immunol       Date:  2021-12-08       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.